All | Group I | Group II | p-value | |
---|---|---|---|---|
n = 615 | n = 283 | n = 332 | ||
Primary endpoints | ||||
DSWI; n (%) | 10 (1,6) | 4 (1,4) | 6 (1,8) | 0,76 |
SSWI; n (%) | 14 (2,2) | 5 (1,7) | 9 (2,7) | 0,59 |
VHSI; n (%) | 4 (0,6) | 1 (0,3) | 3 (0,9) | 0,63 |
Secondary endpoints | ||||
Respiratory tract infection; n (%) | 23 (3,7) | 12 (4,2) | 11 (3,3) | 0,67 |
Urinary tract infection; n (%) | 46 (7,4) | 26 (9,1) | 20 (6,0) | 0,17 |
All-cause mortality; n (%) | 23 (3,7) | 7 (2,4) | 16 (4,8) | 0,14 |
• Mortality due to infection | 6 (0,98) | 2 (0,71) | 4 (1,20) | |
• Mortality due to other cause | 17 (2,76) | 6 (2,12) | 11 (3,31) |